Abstract: The instant invention relates to liquid crystal media comprising a dielectrically positive component (A), comprising compounds with high values of &Dgr;n of formula I and simultaneously a second dielectrically positive component (B), comprising one or more compounds of formula II wherein the parameters are as defined in the text and to liquid crystal displays comprising these media, in particular to TN-AMD displays.

Abstract: This invention provides chiral thioindigo compounds for doping smectic liquid crystal hosts, wherein the compounds modulate a chiral bulk property of an induced chiral smectic liquid crystal phase upon irradiation at a wavelength in the visible range. Modulation of the chiral bulk property is effected by reversible trans-cis photoisomerization of the compound upon irradiation. The compounds maintain their rod-like shape in both isomeric forms, and hence do not destabilize the chiral smectic liquid crystal phase. Compounds according to the invention are useful in optical devices such as optical switches, displays, and memory.

Abstract: A crosslinking type liquid crystal polymer, an oriented crosslinking film thereof, and a method of producing the oriented crosslinking film are disclosed. The crosslinking type liquid crystal polymer comprises a liquid crystal polymer containing a polyfunctional azide compound represented by the following formula (A);R.sup.1 --(N.sub.3).sub.n (A)wherein R.sup.1 represents an organic group and n represents an integer of from 1 to 5.

Abstract: The present invention concerns finely divided particles of compounds that provide flame retardancy and/or smoke suppressant properties to fibers, textiles, polymeric articles, paper, paint, coating and insulation. More particularly, the present invention concerns colloidal-sized particles of hydrated salts, organic phosphates, metal borates, polyamides, solid halogenated flame retardants with a melting point greater than 250.degree. C., molybdenum compounds, metallocenes, antimony compounds, zinc compounds, bismuth compounds and other solid chemicals which act as flame retardants or smoke suppressants. The present invention also concerns various milling processes to reduce these materials to colloidal sizes and to disperse them in water, organic liquids and meltable solids.

Abstract: Liquid-crystalline allenes of the formula I ##STR1## where M is a mesogenic group,R.sup.1 and R.sup.2 are hydrogen or a C-organic radical having 1-8 carbon atoms,R.sup.3 is a C-organic radical having 1-30 carbon atoms,X.sup.1 is --(CH.sub.2).sub.q --O--(CH.sub.2).sub.p --,--(CH.sub.2).sub.q --NR.sup.4 --(CH.sub.2).sub.p --,--(CH.sub.2).sub.q --CO--O--(CH.sub.2).sub.p --,--(CH.sub.2).sub.q --O--CO--(CH.sub.2).sub.p --,--(CH.sub.2).sub.q --CO--NR.sup.4 --(CH.sub.2).sub.p -- or--(CH.sub.2).sub.q --NR.sup.4 --CO--(CH.sub.2).sub.p --,R.sup.4 is hydrogen or an alkyl radical having 1-4 carbon atoms,p is from 1 to 20, andq is from 0 to 20,where the definitions of R.sup.2 and R.sup.3 can also be interchanged, are used in optical display elements.

Abstract: Pharmaceutical compounds of the formula ##STR1## in which n is 0, 1 or 2 and R.sup.1 is attached at any of the positions 7, 8, 9 or 10, and each R.sup.1 is halo, carboxy, trifluoromethyl, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, hydroxy-C.sub.1-4 alkyl, hydroxy-C.sub.1-4 alkoxy, nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, --COOR.sup.5 where R.sup.5 is an ester group, --COR.sup.6, --CONR.sup.6 R.sup.7 or --NR.sup.6 R.sup.7 where R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl;R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.2 is furanyl optionally substituted with C.sub.1-4 alkyl;R.sup.3 is nitrile, carboxy, --COOR.sup.8 where R.sup.8 is an ester group, or --CONR.sup.9 R.sup.10 where R.sup.9 and R.sup.10 are each hydrogen or C.sub.1-4 alkyl; andR.sup.4 is --NR.sup.11 R.sup.12, --NR.sup.11 COR.sup.

Abstract: Benzene derivatives of the formula I ##STR1## in which R, A.sup.1, A.sup.2 X, L.sup.1, L.sup.2 m and n are as defined in claim are suitable as components of liquid-crystalline media.

Abstract: A chemically defined polymeric carrier comprising a series of .alpha.-amino acids in any combination containing side chains to which diagnostic/therapeutic and chelating agents can be covalently joined through cleavable linkers either directly or covalently joined through cleavable linkers after chemical modification of the side chains. Hydrazone, disulfide, and ester linkages in any combination can be present in the polymeric carrier between the side chains of the .alpha.-amino acids and the agents. The presence of a particular covalent linkage between the side chain and the agent in the carrier is determined by the functional group present in the side chain of the .alpha.-amino acid and the functional group present in the agent. The .alpha.-amino acids with side chains to which agents do not covalently join can function as spacers to minimize interaction between bulky molecules attached to the polymeric carrier. In addition, those .alpha.

Abstract: This invention relates to chelating agents useful for coupling metal ions to biologically active molecules. In particular, isothiocyanate derived thiocarbonyls for chelating metals such as technetium are provided that can be conjugated to a targeting molecule such as an antibody, a peptide or a protein.

Abstract: A glassy thermotropic chiral nematic liquid crystalline composition comprises a glassy chiral nematic compound of low molar mass that includes a cycloaliphatic radical, a nematogenic moiety, and a chiral moiety, or a mixture of a nematic liquid crystalline compound of low molar mass that includes a cycloaliphatic radical and a nematogenic moiety and a chiral compound of low molar mass that includes a chiral moiety. Each cycloaliphatic radical contains 4 to about 18 carbon atoms. An optical device is formed from the described glassy thermotropic chiral nematic liquid crystalline composition.

Abstract: An electrooptical systemwhich between 2 electrode layers contains a PDLC film comprising a liquid crystal mixture forming microdroplets in an optically isotropic, transparent polymer matrix,in which one of the refractive indices of the liquid crystal mixture is matched to the refractive index of the polymer matrix, andwhich in one of the two switching states has reduced transmission compared with the other state independent of the polarization of the incident light,characterized in that the precursor of the PDLC film comprisesa) 50-90 wt. % of a liquid crystal mixture containing one or more compounds of the formula I ##STR1## b) 15-49.5 wt. % of the precursor of the polymer matrix.

Abstract: A liquid crystal device wherein the liquid crystal material is a siloxane-containing compound characterised by the the general formula ##STR1## wherein R is a C.sub.1-10 alkyl or ##STR2## each R' is a C.sub.1-4 alkyl, T is ##STR3## X is an alkyl or halogen-substituted alkyl group having at least one chiral center, Y is F, m is 0, 1 or 2 and n is 10, 11 or 12. Also claimed is a device wherein the liquid crystal material is disposed between a pair of substrates.

Abstract: The invention concerns a radiopharmaceutical product having in particular a cerebral tropism comprising a nitruro complex of a transition metal and the method for preparing said product. This complex satisfies the formula (M.tbd.N)L.sup.1 L.sup.2 (I) in which M is a transition metal, such as Tc99m, Re 186 or Re188, and L.sup.1 and L.sup.2, which may be identical or different, satisfy the formula ##STR1## in which R.sup.1 and R.sup.2 may be alkyl radicals, V and W may be O, S or Se, n=0 or 1, l=0 or 1, m=0 or 1, and X represents N--C, C, or As.

Abstract: Rhenium complexes of formula (I), radiolabelled complexes thereof or pharmaceutically acceptable salts thereof: ##STR1## wherein R is straight or branched chain C.sub.1-10 alkyl, C.sub.1-10 alkenyl, C.sub.1-10 alkynyl optionally substituted by cycloalkyl or aryl; C.sub.1-10 cycloalkyl optionally substituted by straight or branched chain alkyl, alkenyl, alkynyl or aryl; or aryl optionally substituted by straight or branched chain alkyl, alkenyl, alkynyl or cycloalkyl for use in liver cancer therapy and metastasis of cancer.

Abstract: Disclosed are certain cocaine analogs useful for imaging of cocaine receptors and dopamine receptors. Also disclosed are analogs useful for imaging diagnostics for Parkinson's disease.

Abstract: A group of functionalized polyamine chelants that form complexes with rhodium are disclosed. The rhodium complexes can be attached to an antibody or antibody fragment and used for therapeutic or diagnostic purposes.

Abstract: An optically erasable read-and-write liquid crystal/side-chain liquid crystalline polymer composition, and method of making recordation on the same, are disclosed. The liquid crystal/side-chain liquid crystalline polymer composition of the present invention comprises: (1) from 45% to 85% of a nematic type ester-based liquid crystal and (2) from 15% to 55% of side-chain polymethylsiloxane liquid crystalline polymer having a molecular weight between about 4,000 to 10,000. The side-chain polymethylsiloxane polymer is prepared by graft-polymerization of a biphenyl derivative having a terminal saturated or unsaturated alkyl group, which can be either symmetrical or asymmetrical, with a polymethylsiloxane to form the liquid crystal side-chain polymethylsiloxane polymer of the present invention. Data are recordable on the recording medium of the present invention using a laser beam heating, and are erasable by applying an external electrical field.

Abstract: Compounds containing a 4-[(E)-alk-2-enoyloxy]benzoate group and liquid crystalline mixtures which contain such compounds and the use of such compounds and, respectively, mixtures in electro-optical indicating devices.The compounds are of the formula ##STR1## wherein R.sup.1 is alkyl with 1 to 12 carbon atoms;X.sup.1, X.sup.3 each independently are halogen or hydrogen; andX.sup.2 is halogen or cyano.

Abstract: A liquid crystal display is made from an encapsulated liquid crystal structure comprising a liquid crystal composition dispersed in a containment medium. Selected additives may be added to the encapsulated liquid crystal structure to improve performance characteristics such as the operating field, the hysteresis, and the voltage holding ratio.

Abstract: The present invention relates to compounds of the formula ##STR1## in which Z is a halogen atom, a cyano group or a hydroxyl group,n is 0, 1 or 2,R' is a radical of the formulaR"'--[Si(R*).sub.2 ].sub.x (CH.sub.2).sub.y R""-- (9),in whichx is the number 0 or 1,y is an integer from 1 to 18,R"'is a defined in the description,R* is identical or different, optionally substituted C.sub.1 - to C.sub.18 -hydrocarbon or hydrocarbonoxy radicals,R"" is a phenylene or biphenylene radical or a radical of the formula --E--, whereE is a divalent radical of the formula --O-- or --[Si(R*).sub.2 ].sub.z --, andz is the number 0 or 1,and the compounds contain at least one group of the formula --Si(R*).sub.2 -- per molecule, and the radicalR" is a cholesteryl radical, a radical as defined for R* or a radical of the formula --C.sub.6 H.sub.4 --R*,and the preparation and use thereof.